VEGFA and neoplasm: While TRPV4 promotes cancer cells proliferation, migration and extravasation, activation of TRPV4 in endothelial cells suppresses vascular endothelial growth factor signaling, normalizes tumor vasculature, inhibits tumor growth and metastasis, and improves cancer therapy [154, 155].